In SURMOUNT-1 (Phase 3), tirzepatide at 15 mg produced 22.5% body weight loss at 72 weeks
While there is currently a registered study to examine the effect of sulforaphane in patient populations with attention-deficit disorder with or without hyperactivity in children 612 years old (NCT06594536), as well as a study currently recruiting to evaluate the effects of sulforaphane in PD patients (NCT05084365), and a clinical study registered to examine AD (NCT04213391), there remains large gaps in the literature regarding the efficacy of sulforaphane as a treatment for neurological disorders
The 3W Clinic Intensive Dr
Side effects also increase with dose, primarily gastrointestinal symptoms like nausea, vomiting, and diarrhea
The vitamin's role in homocysteine metabolism is particularly relevantdeficiency leads to elevated homocysteine levels and methylmalonic acid, which may contribute to neurological dysfunction
Detailed Description The present invention will be described in detail with reference to examples, but the present invention is not limited to these examples
